Kamran Khoobehi
Cardiovascular Disease · Metairie, LANPI 1548282577
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,253 of the $11,827 with a category attached, or 61.3%. 22 manufacturers reported payments, led by AbbVie at 56.5% of the total.
Across 206 payments — averaging $57.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Musculoskeletal Transplant Foundation Inc.$1K
- Integra Lifesciences Corporation$723
- Axogen$598
- Revance Therapeutics, Inc.$330
- TELA Bio, Inc.$227
- plus $2K from 16 others
Across 2 payments — averaging $760.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Speaking & faculty fees$6696%
- Travel & lodging$1,27111%
- Food & beverage$7,25361%
- Education$110%
- Gifts$2,05417%
- Other$5705%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 158 | $6,680 |
| Musculoskeletal Transplant Foundation Inc. | 6 | $1,435 |
| Integra Lifesciences Corporation | 3 | $723 |
| Axogen | 5 | $598 |
| Revance Therapeutics, Inc. | 8 | $330 |
| TELA Bio, Inc. | 2 | $227 |
| Davol Inc. | 2 | $222 |
| Acera Surgical, Inc. | 2 | $207 |
| Organogenesis Inc. | 2 | $205 |
| Sientra, Inc. | 2 | $155 |
| BD | 1 | $153 |
| Smith+Nephew | 2 | $125 |
| Baxter Healthcare | 2 | $124 |
| Tepha Inc | 1 | $119 |
| Avita Medical Americas, LLC | 1 | $118 |
| Kls-martin L.p. | 1 | $115 |
| Polynovo North America LLC | 1 | $113 |
| Mentor Worldwide LLC | 2 | $81 |
| Pacira Pharmaceuticals Incorporated | 2 | $33 |
| UCB, Inc. | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$2,533
- INTEGRA$782
- AxoGuard Nerve Connector$437
- AxoGuard Nerve Protector$437
- BOTOX$405
- NATRELLE SALINE-FILLED BREAST IMPLANTS$359
- Phasix Mesh$287
- AVANCE NERVE GRAFT$273
- MICROMATRIX$245
- OMNIGRAFT$153
- INTEGRA DERMAL REGENERATION TEMPLATE$153
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$152
- PICO 7 Single Use Negative Pressure Wound Therapy$124
- PICO 7Y Single Use Negative Pressure Wound Therapy$124
- Acticoat Range$124
- GalaFLEX$119
- RECELL$118
- Cohealyx$118
- PERMEADERM$118
- Restrata Wound Matrix$117
How this compares
$11,827 in reported general payments places this provider in the 80th percentile of 281 cardiovascular disease providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 18 | $347 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $279 |
| Cephalexin | 28 | $163 |
| Methylprednisolone | 15 | $142 |
| Promethazine Hcl | 22 | $79 |
| Lorazepam | 20 | $24 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Metairie
- Homeyar DinshawMetairie$14K
- Keith FerdinandNew Orleans$239K
- Carl LavieNew Orleans$228K
- Imran ChaudryMonroe$202K
- Corey FosterLake Charles$158K
- George KaramBaton Rouge$110K
- Harry HawthorneAlexandria$89K
- Mazen IqbalMonroe$82K
- Darrell SoletMorgan City$81K
- Ghiath MikdadiHammond$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.